Matt Phipps
Stock Analyst at William Blair
(3.88)
# 1,905
Out of 4,463 analysts
554
Total ratings
47.3%
Success rate
4.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matt Phipps
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMAB Genmab | Maintained: Buy | n/a | $27.64 | - | 23 | Jun 30, 2026 | |
| EVMN Evommune | Downgraded: Hold | n/a | $12.82 | - | 16 | Jun 29, 2026 | |
| ABBV AbbVie | Reiterated: Buy | n/a | $251.06 | - | 10 | Jun 22, 2026 | |
| INCY Incyte | Maintained: Hold | n/a | $113.81 | - | 45 | Jun 15, 2026 | |
| CNTX Context Therapeutics | Reiterated: Buy | n/a | $0.6083 | - | 11 | Jun 15, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | n/a | $13.29 | - | 12 | Jun 11, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | n/a | $17.28 | - | 21 | Jun 8, 2026 | |
| AUTL Autolus Therapeutics | Maintained: Buy | n/a | $1.58 | - | 40 | Jun 2, 2026 | |
| JSPR Jasper Therapeutics | Maintained: Hold | n/a | $0.4545 | - | 18 | Jun 1, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | n/a | $21.81 | - | 5 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.28 | - | 20 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $107.00 | - | 12 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.88 | - | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.29 | - | 15 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.77 | - | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 → $14 | $14.66 | -4.50% | 18 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $909.50 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $35.17 | - | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $13 | $15.38 | -15.47% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.18 | - | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $361.33 | - | 38 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $56.44 | - | 58 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $240.66 | - | 1 | Jan 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 | $79.19 | +47.44% | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $90.21 | - | 1 | Sep 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.41 | - | 19 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.46 | - | 8 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $498.01 | n/a | 1 | Jun 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $72.50 | n/a | 1 | Jun 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.11 | n/a | 5 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.44 | n/a | 11 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.2 | $14.81 | n/a | 1 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.978 | n/a | 13 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $138.26 | n/a | 19 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.37 | n/a | 14 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.0004 | n/a | 11 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.9798 | n/a | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $209.74 | n/a | 26 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $64.39 | n/a | 1 | Jun 11, 2021 |
Genmab
Jun 30, 2026
Maintained: Buy
Price Target: n/a
Current: $27.64
Upside: -
Evommune
Jun 29, 2026
Downgraded: Hold
Price Target: n/a
Current: $12.82
Upside: -
AbbVie
Jun 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $251.06
Upside: -
Incyte
Jun 15, 2026
Maintained: Hold
Price Target: n/a
Current: $113.81
Upside: -
Context Therapeutics
Jun 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.6083
Upside: -
Climb Bio
Jun 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.29
Upside: -
Cullinan Therapeutics
Jun 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $17.28
Upside: -
Autolus Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $1.58
Upside: -
Jasper Therapeutics
Jun 1, 2026
Maintained: Hold
Price Target: n/a
Current: $0.4545
Upside: -
Jade Biosciences
Jun 1, 2026
Maintained: Buy
Price Target: n/a
Current: $21.81
Upside: -
May 19, 2026
Maintained: Buy
Price Target: n/a
Current: $7.28
Upside: -
May 18, 2026
Maintained: Buy
Price Target: n/a
Current: $107.00
Upside: -
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $10.88
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $13.29
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $5.77
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $71 → $14
Current: $14.66
Upside: -4.50%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $909.50
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $35.17
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $13 → $13
Current: $15.38
Upside: -15.47%
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $2.18
Upside: -
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $361.33
Upside: -
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $56.44
Upside: -
Jan 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $240.66
Upside: -
Oct 11, 2025
Reiterated: Buy
Price Target: $117
Current: $79.19
Upside: +47.44%
Sep 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $90.21
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $3.41
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $11.46
Upside: -
Jun 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $498.01
Upside: n/a
Jun 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $72.50
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $1.11
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $1.44
Upside: n/a
Mar 29, 2025
Initiated Coverage: Buy
Price Target: $1.2
Current: $14.81
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $0.978
Upside: n/a
Jan 3, 2022
Maintained: Buy
Price Target: n/a
Current: $138.26
Upside: n/a
Dec 7, 2021
Maintained: Buy
Price Target: n/a
Current: $11.37
Upside: n/a
Dec 7, 2021
Maintained: Hold
Price Target: n/a
Current: $0.0004
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: n/a
Current: $0.9798
Upside: n/a
Jul 23, 2021
Rated: Buy
Price Target: n/a
Current: $209.74
Upside: n/a
Jun 11, 2021
Maintained: Buy
Price Target: n/a
Current: $64.39
Upside: n/a